Oliver Lagore Vanvalin Investment Group’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.62M | Buy |
+1,965
| New | +$1.62M | 0.64% | 40 |
|
|
2024
Q4 | $1.21M | Buy |
1,568
+155
| +11% | +$120K | 0.31% | 64 |
|
|
2024
Q3 | $1.25M | Buy |
1,413
+166
| +13% | +$147K | 0.33% | 62 |
|
|
2024
Q2 | $1.13M | Buy |
1,247
+362
| +41% | +$328K | 0.32% | 59 |
|
|
2024
Q1 | $689K | Buy |
885
+498
| +129% | +$387K | 0.2% | 77 |
|
|
2023
Q4 | $226K | Buy |
387
+84
| +28% | +$49K | 0.08% | 103 |
|
|
2023
Q3 | $163K | Buy |
303
+60
| +25% | +$32.2K | 0.06% | 131 |
|
|
2023
Q2 | $114K | Buy |
243
+15
| +7% | +$7.04K | 0.04% | 162 |
|
|
2023
Q1 | $78.3K | Buy |
228
+75
| +49% | +$25.8K | 0.03% | 150 |
|
|
2022
Q4 | $56K | Sell |
153
-2
| -1% | -$732 | 0.03% | 172 |
|
|
2022
Q3 | $50K | Buy |
155
+38
| +32% | +$12.3K | 0.03% | 168 |
|
|
2022
Q2 | $38K | Buy |
117
+2
| +2% | +$650 | 0.02% | 199 |
|
|
2022
Q1 | $33K | Buy |
+115
| New | +$33K | 0.02% | 204 |
|